Texas Diabetes Institute, University Health System

San Antonio, Texas 78207

6 studies enrolling now · 10 studies all time

What they study most

Aging, COVID-19, Diabete Mellitus, Gastric Bypass, Heart Failure, Heart Failure With Reduced Ejection Fraction, Hypoglycemia, Hypoglycemia After Gastric Bypass, Mitochondrial Metabolism Disorders, Non-Alcoholic Fatty Liver Disease, Non-Diabetic, Post Bariatric Surgery

Studies at this site

• The Role of Glucagon in Glucose Metabolism in Humans With and Without Bariatric Surgery — Recruiting now
• Ketones, SGLT2, HFrEF — Recruiting now
• Quantifying Hepatic Mitochondrial Fluxes in Humans — Recruiting now
• Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery — Recruiting now
• Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass — Recruiting now
• The Effects of Bariatric Surgeries on Glucose Metabolism — Recruiting now
• Long-Term Sequelae of SARS-COV-2 Infection: Diabetes Mellitus — Completed
• Ketones, Muscle Metabolism, and SGLT2 Inhibitors - Protocol 1 — Completed
• SGLT2 Inhibition in Older Obese Adults With Pre-diabetes — Completed
• Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of G-Pen(TM) (Glucagon Injection) to Treat Severe Hypoglycemia — Completed